Evidence map›Paper›PMID 9120007›Full record

ArticleThe Journal of clinical investigation1997

Neutralization of interferon-gamma exacerbates pneumocystis-driven interstitial pneumonitis after bone marrow transplantation in mice.

B A Garvy, F Gigliotti, A G Harmsen

Abstract read
In one paragraph

Article in The Journal of clinical investigation, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Immune responses of different hosts toEuropean respiratory review : an official journal of the European Respiratory Society · 2025
    Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Contribution of T cell subsets to the pathophysiology of Pneumocystis-related immunorestitution disease.American journal of physiology. Lung cellular and molecular physiology · 2006
    Article
  7. Article
  8. Article
  9. Treatment of infection due to Pneumocystis carinii.Antimicrobial agents and chemotherapy · 1998
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

B A GarvyThe Trudeau Institute, Saranac Lake, New York 12983, USA. bgarvy@northnet.org
F Gigliotti
A G Harmsen

Funding

RECONSTITUTION OF IMMUNITY TO PNEUMOCYSTIS IN SCID MICER01HL055002 · NHLBI · TRUDEAU INSTITUTE, INC. · PI HARMSEN, ALLEN G · 1995 to 2009
$3.5M
MONOCLONAL ANTIBODIES FOR THE STUDY OF P. CARINIIR01AI023302 · NIAID · UNIVERSITY OF ROCHESTER · PI GIGLIOTTI, FRANCIS · 1986 to 2009
$3.1M
NHLBI NIH HHS HL55002NIAID NIH HHS AI-23302
6 · The paper itself

Abstract

The role of IFNgamma in the development of infection-driven interstitial pneumonitis in a model of murine graft-versus-host disease was investigated. Mice were given either syngeneic or allogeneic bone marrow transplants along with lung Pneumocystis carinii infections and were treated with either control mAb or anti-IFNgamma mAb. At day 21 after transplant, lung weights were elevated nearly twofold in all groups. By day 41, mice in all groups had cleared the P. carinii but only the mice given allogeneic transplants and anti-IFNgamma had increased lung weights. Increased lung weights in the anti-IFNgamma-treated mice corresponded to alveolar infiltration of eosinophils, neutrophils, and multinucleated giant cells and exacerbated interstitial pneumonitis compared with mice treated with control antibody. Intracellular staining indicated that there were 3- to 10-fold more CD4+ cells producing IFNgamma than those producing IL-4 in the lung lavages of mice given either syngeneic or allogeneic transplant. Treatment of transplanted mice with anti-IFNgamma resulted in a significant decrease in IFN-gamma-producing CD4+ and CD8+ cells in the lung lavages but no change in the number of IL-4-producing CD4+ cells. These data indicate that IFNgamma is critical for controlling the development of P. carinii-driven interstitial pneumonia after either syngeneic or allogeneic bone marrow transplant in mice.

Indexed as

AnimalsAntibodies, MonoclonalBone Marrow TransplantationCD4-Positive T-LymphocytesFemaleGraft vs Host DiseaseInterferon-gammaInterleukin-4Lung Diseases, InterstitialMiceMice, Inbred BALB CMice, SCIDPneumonia, PneumocystisAntibodies, MonoclonalInterferon-gammaInterleukin-4

Identifiers

PMID9120007
PMCPMC507983

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.